Effect of Intrathecal vs Intraarticular Dexmedetomidine on Postoperative Pain Following Arthroscopy

Not Applicable

Completed

• Conditions: Postoperative Pain
• Interventions: Drug: Intraarticular Dexmedetomidine; Drug: Intrathecal Dexmedetomidine; Drug: Bupivacaine

• Registration Number: NCT02581566
• Lead Sponsor: Assiut University

Brief Summary

Comparison between intrathecal Dexmedetomidine versus Intraarticular Dexmedetomidine on postoperative pain after knee arthroscopy.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07
• Study First Submitted: 2015-10-18
• Study First Submitted QC: 2015-10-19
• Study First Posted: 2015-10-21
• Primary Completion: 2016-04
• Study Completion: 2016-04
• Status Verified: 2019-03
• Last Update Submitted: 2019-03-11
• Last Update Posted: 2019-03-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Adult patients, ASA I-II, undergoing knee arthroscopy under spinal anesthesia.

Exclusion Criteria

• Absolute or relative contraindications to spinal anesthesia, allergy to dexmedetomidine or chronic pain treatment.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intraarticular Dexmedetomidine Group	Intraarticular Dexmedetomidine	30 patients will be given Intraarticular Dexmedetomidine plus Intrathecal Bupivacaine
Intrathecal Dexmedetomidine Group	Intrathecal Dexmedetomidine	30 patients will be given Intrathecal Dexmedetomidine plus Intrathecal Bupivacaine
control Group	Bupivacaine	30 patients will be given Intrathecal Bupivacaine

Primary Outcome Measures

Name	Time	Method
postoperative pain	24 hours	Assesment is done by Visual Analog Scale

Secondary Outcome Measures

Name	Time	Method
c-reactive protein	24 hours

Trial Locations

Locations (1)

Assiut University Hospital; 🇪🇬 Assiut, Egypt